IMood Journal

Listed in: General mental health  
IMood Journal

Available on:

(click to download)

Supported languages:

English / Russian


Android: £0.82 [approximately €1.16, $1.55], Apple: £1.49 [approximately €2.11, $2.31]

Diary for recording moods.

Approved by


English / Russian

Countries of use

Any in which the user is familiar with one of these languages


Android: £0.82 [approximately €1.16, $1.55], Apple: £1.49 [approximately €2.11, $2.31]


Inexika Inc
(Based in Russia)


Same as technical developer

Medical Adviser

Same as technical developer


Allows networking with other people like me / Family / Friends Allows networking with other people like me / Family / Friends
Reminders Reminders
Support to deal with symptoms/disabilities Support to deal with symptoms/disabilities
Self-monitoring Self-monitoring
Trackers Trackers
Information Information


Diary in which the user can record personal moods with the aim of identifying trends, or even underlying medical conditions. Allows thoughts, experiences, emotions and overall wellbeing to be logged. Associations between moods and experiences can be established, and patterns of moods recognised. The history of records can be browsed. Medications and sleep can be tracked. Provides reminders when entries are due to be made. Moods recorded can be shared with friends on Facebook. Records can be exported to PDF.

Tags: Health, Wellness & Care in the Community (HWCC)


Reviewer: Person with bipolar disorder, USA
Review: "I have bipolar disorder, and this app has been extremely helpful in charting my moods, and the events surrounding them, so that I can better prepare for future events. It is an awesome app. I have recommended it to others, and they are using it, and getting benefit. My therapist is also using it. I print out a copy of my mood history, and my psychiatrist loves it. The app really helps him with managing my medications. Really great app. I have used it for several months, and I never last at anything that long. I don't see any drawbacks or weaknesses with the app."
Source: PatientView survey, November 2013
Usage: 21%-30%
Weblink of reviewer: -

Your comments

all comments are moderated. View our comments policy →
comments powered by Disqus


is brought to you
by Patient View